A carregar...
Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics
Upadacitinib is a novel selective Janus kinase 1 inhibitor developed for treatment of rheumatoid arthritis and other autoimmune diseases. The objective of this study was to assess the pharmacokinetics and safety of a single upadacitinib dose in subjects with normal renal function and in subjects wit...
Na minha lista:
| Publicado no: | J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590375/ https://ncbi.nlm.nih.gov/pubmed/30633369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1375 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|